Skip to the reading
The BPC
question kit

A guide to checking care

Your notes
Chapter index

Which peptide is offered

Get clear on what it is.

Before weighing an offer, ask the provider to name the substance and explain what it is meant to do.

It is a lab-made peptide.

BPC-157 is a chain made in a lab, with fifteen amino acids—the small units used to build proteins.

A short chain like this is called a peptide.

The design draws on a protein fragment reported to occur in human stomach juice.

Read the basisFederal medicines review, PDF

The name can sound familiar or reassuring. Keep the next question practical: what has been shown in people?

A name does not tell you what is inside.

As of September 28, 2026, the BPC-157 name was used for different versions of the ingredient itself.

What differs is the substance itself, rather than its delivery as a shot or pill.

This naming problem was identified by the U.S. medicines agency, the Food and Drug Administration (FDA).

The FDA warns that this can lead to a person receiving a different substance from the one ordered.

Read the basisFDA findings on naming, PDF

Healing claims need human evidence.

In an injury study, one group may get BPC-157 while another gets a look-alike treatment with no active medicine.

As of September 28, 2026, no finished study of this kind had reported results.

The published knee-pain report had no group to compare with the people who received it.

Read the basisFDA review of human studies, PDF

Ask to see the study behind the claim. Then ask whether it studied people with the same problem as yours.

Read the evidence questions